These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 26045809)
1. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma. Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma. Tian ZZ; Guo XJ; Zhao YM; Fang Y Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma. Li F; Cao L; Hang D; Wang F; Wang Q Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868 [TBL] [Abstract][Full Text] [Related]
4. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma. Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852 [TBL] [Abstract][Full Text] [Related]
5. High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients. Uzan VR; Lengert Av; Boldrini É; Penna V; Scapulatempo-Neto C; Scrideli CA; Filho AP; Cavalcante CE; de Oliveira CZ; Lopes LF; Vidal DO PLoS One; 2016; 11(6):e0156774. PubMed ID: 27253450 [TBL] [Abstract][Full Text] [Related]
6. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA HULC inhibits proliferation, migration, invasion, and promotes apoptosis by sponging miR-122 in osteosarcoma. Kong D; Wang Y J Cell Biochem; 2018 Jan; 119(1):1050-1061. PubMed ID: 28688193 [TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA HULC Promotes Progression of Bone Neoplasms. Zhang T; Wan CY; Mei XL; Jia P; Wang MJ Med Sci Monit; 2018 Aug; 24():5754-5760. PubMed ID: 30120220 [TBL] [Abstract][Full Text] [Related]
10. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. Cao S; Liu W; Li F; Zhao W; Qin C Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis. Zhu KP; Zhang CL; Shen GQ; Zhu ZS Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of long noncoding RNA CCAL predicts poor patient prognosis and promotes tumor metastasis in osteosarcoma. Zhou DK; Yang XW; Li H; Yang Y; Zhu ZJ; Wu N Int J Biol Markers; 2017 Mar; 32(1):e108-e112. PubMed ID: 28009431 [TBL] [Abstract][Full Text] [Related]
14. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells. Qu G; Ma Z; Tong W; Yang J Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204 [TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma. He R; Wu JX; Zhang Y; Che H; Yang L Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767 [TBL] [Abstract][Full Text] [Related]
16. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma. Cai L; Lv J; Zhang Y; Li J; Wang Y; Yang H J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868 [TBL] [Abstract][Full Text] [Related]
17. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma. Liu W; Zhao ZY; Shi L; Yuan WD Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657 [TBL] [Abstract][Full Text] [Related]
18. High expression of long non-coding RNA XIST in osteosarcoma is associated with cell proliferation and poor prognosis. Li GL; Wu YX; Li YM; Li J Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2829-2834. PubMed ID: 28682435 [TBL] [Abstract][Full Text] [Related]
19. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro. Wang Y; Yao J; Meng H; Yu Z; Wang Z; Yuan X; Chen H; Wang A Mol Med Rep; 2015 Apr; 11(4):2534-40. PubMed ID: 25434862 [TBL] [Abstract][Full Text] [Related]
20. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]